Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;

The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease Mingkai Li; Ying Lin; Hongsheng Yu; Weichun Lin; Jianning Chen; Yidong Yang; Bin Wu;

From NAFLD to MASLD: When metabolic comorbidity matters Shan Hong; Lei Sun; Yiwei Hao; Ping Li; Yuling Zhou; Xiuxia Liang; Julong Hu; Hongshan Wei;